Activated charcoal: benefits, dosage, contraindications

Mis à jour le

Plant-based activated charcoal is a carbon-rich, porous material obtained by calcining wood (or other materials) heated to a very high temperature in the absence of air. The charcoal is then activated by increasing the number of pores, which increases its surface area. This is achieved by heating it at high temperature in the presence of steam or carbon dioxide, or with an activating agent such as phosphoric acid or zinc chloride. Activated charcoal is widely used to treat drug overdoses and poisonings. Activated charcoal can be prepared from plant byproducts such as coconut shells, cherry and olive pits, or date pits. The adsorptive power of activated charcoals is essentially attributed to porosity and specific surface area (surface area per unit mass, expressed in m²/g), representing the area available to adsorb a monolayer of molecules. The surface area developed by activated charcoal is substantial: 1 g of activated charcoal has a specific surface area between 400 and 2,500 m²/g. Activated charcoal demonstrated its ability to prevent toxicity when two of its early pioneers, Bertrand (1813) and Touéry (1831), publicly ingested arsenic and strychnine, respectively, with activated charcoal and survived. Subsequently, researchers demonstrated in vitro the action of activated charcoal on a wide range of toxins, notably morphine, barbiturates, salicylates, and other drugs. In addition to its role in the neutralizing toxins, activated charcoal has been shown to adsorb gases, which suggests it could play a role in reducing flatulence. Because of its adsorbent character (that is, attracting substances to the surface of the material), activated charcoal can help treat liver and kidney disorders. Oral intake of activated charcoal can lower cholesterol levels and reduce elevated bile acid levels.

Scientific name(s)

Carbo vegetabilis

Family or group: 

Superfood


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Detoxification
✪✪✪✪

Oral administration of activated charcoal appears to be effective when it is part of the standard treatment for certain acute poisonings. Single doses of activated charcoal, 25 to 100 g in adults (10 to 50 g in children, depending on age), are effective at preventing the absorption of certain drugs if taken within one hour of ingestion.

Posologie

posologieOral

posologie10 g


Diarrhea
✪✪✪✪✪

Preliminary clinical research conducted in children treated with irinotecan (chemotherapy) shows that taking 250 mg of activated charcoal the day before the first infusion, then every 8 hours until the end of the cycle, reduces the risk of diarrhea by 60% compared with no treatment. Activated charcoal also appears to reduce the risk of severe diarrhea by 92% and the interruption of chemotherapy by 87% in these patients.

Posologie

posologieOral

posologie250 mg


Digestive disorders
✪✪✪✪✪

A preliminary clinical study conducted in adults suffering from functional dyspepsia shows that taking a specific combination containing 280 mg of activated charcoal, 90 mg of simethicone (medication) and 180 mg of magnesium oxide three times a day for one month reduces dyspepsia symptoms, such as postprandial fullness, epigastric pain and abdominal bloating, compared with placebo.

Posologie

posologieOral

posologie150 - 840 mg


Flatulence
✪✪✪✪✪

Preliminary clinical research shows that taking 582 mg of activated charcoal after a meal significantly reduces the incidence of flatulence compared with placebo. On average, subjects taking activated charcoal reported fewer than 3 episodes of flatulence over 8 hours, compared with more than 14 episodes of flatulence in those taking placebo. However, other preliminary clinical research shows that taking 520 mg of activated charcoal at breakfast, lunch, dinner, and bedtime for 7 days does not significantly reduce excessive gas or the total number of flatulence episodes compared with baseline.

Posologie

posologieBy mouth

posologie582 mg


Properties


Digestive effect

full-leaffull-leaffull-leaffull-leaf

Activated charcoal is capable of adsorbing many drugs; it has been shown to adsorb gases, which suggests it may play a role in reducing flatulence after gas-producing meals. Preliminary clinical evidence suggests that activated charcoal lowers bile acid levels in pregnant patients with cholestasis (serum bile acid level is associated with cholestasis symptoms).

Usages associés

Diarrhea, digestive disorders, flatulence

Depurative

full-leaffull-leaffull-leafempty-leaf

Activated charcoal is widely recognized for its effectiveness in reducing absorption from most common toxic ingestions. Activated charcoal adsorbs many drugs, which increases clearance and decreases elimination half-life. It binds unabsorbed drugs in the gastrointestinal tract. It also binds drugs that diffuse or are transported from the circulation into the intestine, and interrupts the enterohepatic circulation of drugs. Through this latter mechanism, it may reduce exposure to drugs administered intravenously, including amiodarone, azithromycin, paracetamol (acetaminophen), aspirin, ceftriaxone, doxycycline, lorazepam, methotrexate, metronidazole, morphine, phenytoin, and valproate.

Usages associés

Detoxification

Cholesterol-lowering

full-leafempty-leafempty-leafempty-leaf

Activated charcoal is thought to lower serum cholesterol levels by interfering with the enterohepatic circulation of bile acids. Cholesterol is required for bile acid production and is used in greater amounts when bile acid synthesis is increased to normalize levels.


Safe dosage

Adult: 500 mg - 10000 mg

Activated charcoal is administered in single doses up to 100 g. Lower doses, up to 3.6 grams per day, have been used for up to 3 years. When taking activated charcoal, stools become dark in color.


Interactions

Médicaments

Oral contraceptives: moderate interaction

Activated charcoal, taken at a dose of 5 g four times a day for 3 days, can bind to oral contraceptives and reduce their absorption, thereby limiting their effectiveness and increasing the risk of contraceptive failure. However, some clinical research shows that the risk of this interaction is minimal when activated charcoal is taken either 3 hours after or at least 12 hours before oral contraceptives.

Oral medications: strong interaction

Activated charcoal adsorbs various medications and can reduce their absorption and/or their half-life. Examples of affected drugs include: acetaminophen, aminophylline, amiodarone, atenolol, carbamazepine, dapsone, digoxin, disopyramide, fluoxetine, indomethacin, moxifloxacin, nadolol, phenytoin, phenobarbital, piroxicam, quinine, sotalol, theophylline, tricyclic antidepressants, valproate, verapamil, antihypertensive medications, and drugs for rheumatic conditions. Avoid co-administration.


Precautions

Breastfeeding woman: use with caution

Charcoal has been used safely when administered orally and for short-term use.

Pregnant woman: use with caution

Activated charcoal, 50 g three times daily for 8 days, has been used with apparent safety during pregnancy.


Contraindications

Intestinal obstruction: contraindicated

The use of activated charcoal is contraindicated in cases of intestinal obstruction.